The stock of Lilly(Eli) & Co (LLY) has seen a 0.75% increase in the past week, with a 4.23% gain in the past month, and a -2.26% decrease in the past quarter. The volatility ratio for the week is 1.95%, and the volatility levels for the past 30 days are at 2.82% for LLY. The simple moving average for the last 20 days is 3.85% for LLY stock, with a simple moving average of -3.56% for the last 200 days.
Is It Worth Investing in Lilly(Eli) & Co (NYSE: LLY) Right Now?
Lilly(Eli) & Co (NYSE: LLY) has a price-to-earnings ratio of 88.72x that is above its average ratio. Additionally, the 36-month beta value for LLY is 0.36. There are mixed opinions on the stock, with 14 analysts rating it as a “buy,” 6 rating it as “overweight,” 6 rating it as “hold,” and 0 rating it as “sell.”
The public float for LLY is 850.56M and currently, short sellers hold a 0.85% ratio of that float. The average trading volume of LLY on February 04, 2025 was 3.96M shares.
LLY) stock’s latest price update
The stock price of Lilly(Eli) & Co (NYSE: LLY) has surged by 0.07 when compared to previous closing price of 810.43, but the company has seen a 0.75% gain in its stock price over the last five trading sessions. investopedia.com reported 2025-02-03 that Eli Lilly (LLY) is set to report fourth-quarter earnings before the bell Thursday, with analysts expecting rising sales and profit in the first full quarter since the company’s weight-loss drugs were declared no longer in shortage.
Analysts’ Opinion of LLY
Many brokerage firms have already submitted their reports for LLY stocks, with BofA Securities repeating the rating for LLY by listing it as a “Buy.” The predicted price for LLY in the upcoming period, according to BofA Securities is $997 based on the research report published on December 10, 2024 of the previous year 2024.
Wolfe Research, on the other hand, stated in their research note that they expect to see LLY reach a price target of $1000. The rating they have provided for LLY stocks is “Outperform” according to the report published on November 15th, 2024.
Bernstein gave a rating of “Outperform” to LLY, setting the target price at $1100 in the report published on October 17th of the previous year.
LLY Trading at 3.48% from the 50-Day Moving Average
After a stumble in the market that brought LLY to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -16.61% of loss for the given period.
Volatility was left at 2.82%, however, over the last 30 days, the volatility rate increased by 1.95%, as shares surge +3.25% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +10.64% upper at present.
During the last 5 trading sessions, LLY rose by +0.30%, which changed the moving average for the period of 200-days by +7.54% in comparison to the 20-day moving average, which settled at $780.78. In addition, Lilly(Eli) & Co saw 5.05% in overturn over a single year, with a tendency to cut further gains.
Insider Trading
Reports are indicating that there were more than several insider trading activities at LLY starting from Zakrowski Donald A, who proposed sale 900 shares at the price of $803.38 back on Nov 08 ’24. After this action, Zakrowski Donald A now owns shares of Lilly(Eli) & Co, valued at $723,042 using the latest closing price.
Zakrowski Donald A, the SVP, Finance, & CAO of Lilly(Eli) & Co, sale 900 shares at $803.38 during a trade that took place back on Nov 08 ’24, which means that Zakrowski Donald A is holding 5,480 shares at $723,042 based on the most recent closing price.
Stock Fundamentals for LLY
Current profitability levels for the company are sitting at:
- 0.35 for the present operating margin
- 0.82 for the gross margin
The net margin for Lilly(Eli) & Co stands at 0.2. The total capital return value is set at 0.28. Equity return is now at value 65.75, with 12.54 for asset returns.
Based on Lilly(Eli) & Co (LLY), the company’s capital structure generated 0.69 points at debt to capital in total, while cash flow to debt ratio is standing at 0.19. The debt to equity ratio resting at 2.19. The interest coverage ratio of the stock is 23.91.
Currently, EBITDA for the company is 8.57 billion with net debt to EBITDA at 2.22. When we switch over and look at the enterprise to sales, we see a ratio of 19.53. The receivables turnover for the company is 3.39for trailing twelve months and the total asset turnover is 0.54. The liquidity ratio also appears to be rather interesting for investors as it stands at 1.27.
Conclusion
In conclusion, Lilly(Eli) & Co (LLY) has seen better performance in recent times. Analysts have a mixed opinion on the stock, with some rating it as a “buy” and others rating it as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
